Industry Solutions : Thermo Fisher Scientific
Clinical research is essential for discovering answers to real-world health questions. For this, you need repeatable results, streamlined workflows, and innovative techniques. Explore options for applications,
including
biomarker research,
inherited disorders, cancer research, and the study of infectious diseases.
Learn more about Thermo Scientific Mass Spectrometry
Solutions
for Clinical
Research.
Don't miss this year's scientific program, which will highlight the latest advancements using our comprehensive chromatography and mass spectrometry solutions to enhance clinical laboratory decision-making.
|
We can’t wait to see you in Montreal, Canada in 2025! In the meantime, please check out our key resources below.
Key Resources: We invite you to explore past content, including posters, testimonials, workshop recordings, and more.
FEATURED WEBPAGES >>
2024 POSTERS >>
2024 WORKSHOPS >>
- Tony Maus, Ph.D., Assistant Professor, Department of Laboratory Medicine & Pathology, Mayo Clinic >>
FAIMS: The perfect complement
to
established LC-MS/MS techniques
- Stefani Thomas, Ph.D., Assistant Professor, Department of Laboratory Medicine & Pathology, University of Minnesota Medical School >>
An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples
- Jennifer Van Eyk, Ph.D., Director, Advanced Clinical Biosystems Institute, Cedars-Sinai Heart Institute >>
Paradigm shift in
biomarker translation: A pipeline to generate clinical grade biomarker candidates from DIA-MS discovery
- Yue Xuan, Ph.D., Senior Manager, Precision Medicine, Thermo Fisher Scientific >>
Unlocking the potential of large-cohort proteomics
studies with the Orbitrap Astral MS platform
2023 POSTERS >>
2023 WORKSHOPS >>
- Jessica Colón-Franco, Ph.D., Cleveland Clinic Foundation >>
No child lead behind: Development of a method for lead screening using dried
blood
spots
- Dr. Michael Lutz, Ph.D., Head of Global Business Development, Osteolabs GmbH Germany >>
Advancing ICP-MS to clinical testing: A novel
highly
sensitive diagnostic
platform for early detection and therapeutic monitoring of bone metabolic disorders
- Tony Hu, Ph.D., Professor Tulane University >>
Peptidomic classification of mycobacterial proteins at sub-species resolution
- Ian Lewis, Ph.D., University of Calgary, Alberta >>
LC-MS metabolomics: A new frontier in microbiology diagnostic testing
TESTIMONIALS >>
- Chris Gill, Ph.D., Professor Vancouver Island University >>
Rapid MS tools to help researchers tackle opioid crisis
- Ian Lewis, Ph.D., University of Calgary >>
New frontiers for pathogen detection
- Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota >>
"Biomarker discovery/ biomarker translation is a team sport"
- Erin H. Seeley, Ph.D., University of Texas at Austin >>
"We can do things other labs are not able to do"
- Timothy J. Garrett, Ph.D., Southest Center for Integrated Metabolomics >>
Discover the technology delivering confident results for
health and disease diagnostics